These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1447658)

  • 1. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease.
    Lin CY; Lin CC; Hwang B; Chiang B
    J Pediatr; 1992 Dec; 121(6):924-6. PubMed ID: 1447658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines predict coronary aneurysm formation in Kawasaki disease patients.
    Lin CY; Lin CC; Hwang B; Chiang BN
    Eur J Pediatr; 1993 Apr; 152(4):309-12. PubMed ID: 8482278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of coronary artery aneurysm formation in patients with Kawasaki disease.
    Daniels SR; Specker B; Capannari TE; Schwartz DC; Burke MJ; Kaplan S
    Am J Dis Child; 1987 Feb; 141(2):205-7. PubMed ID: 3812389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute pericardial effusion representing the TNF-α-mediated severe inflammation but not the coronary artery outcome of Kawasaki disease.
    Okada S; Hasegawa S; Suzuki Y; Matsubara T; Shimomura M; Okuda M; Ichiyama T; Ohga S
    Scand J Rheumatol; 2015 May; 44(3):247-52. PubMed ID: 25351965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serum concentration of soluble interleukin-2 receptor in patients with Kawasaki disease.
    Teraura H; Kotani K; Minami T; Takeshima T; Shimooki O; Kajii E
    Ann Clin Biochem; 2017 Mar; 54(2):209-213. PubMed ID: 28081636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of angiogenic activity in the serum from patients with coronary aneurysms due to Kawasaki disease.
    Higashi K; Terai M; Hamada H; Honda T; Kanazawa M; Kohno Y
    Circ J; 2007 Jul; 71(7):1052-9. PubMed ID: 17587710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical Kawasaki disease: coronary aneurysms and thrombocytopenia.
    Kinney JB; Albano E; Krober MS; Stevenson JG
    South Med J; 1992 Jan; 85(1):40-2. PubMed ID: 1734535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease.
    Mitani Y; Sawada H; Hayakawa H; Aoki K; Ohashi H; Matsumura M; Kuroe K; Shimpo H; Nakano M; Komada Y
    Circulation; 2005 Jan; 111(1):38-43. PubMed ID: 15611368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is the determination of procalcitonin useful in Kawasaki disease?].
    Caballero Mora FJ; Alvarez-Coca González J; Alonso Martín B; Martínez Pérez J
    An Pediatr (Barc); 2009 Oct; 71(4):371-2. PubMed ID: 19726253
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum-soluble interleukin-2 receptor levels in Kawasaki disease.
    Lang BA; Silverman ED; Laxer RM; Rose V; Nelson DL; Rubin LA
    J Pediatr; 1990 Apr; 116(4):592-6. PubMed ID: 2319407
    [No Abstract]   [Full Text] [Related]  

  • 11. Regression of coronary aneurysms in patients with Kawasaki syndrome.
    Takahashi M; Mason W; Lewis AB
    Circulation; 1987 Feb; 75(2):387-94. PubMed ID: 3802442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease.
    Lin CY; Lin CC; Hwang B; Chiang BN
    Eur J Pediatr; 1991 Jan; 150(3):179-82. PubMed ID: 1904353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant Coronary Aneurysms in a one-month-old Infant with Kawasaki Disease.
    Kim JH; Kim M; Oh JH; Lee JY; Lee KY; Koh DK
    Indian J Pediatr; 2017 Feb; 84(2):162-163. PubMed ID: 27641973
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreased serum Annexin A1 levels in Kawasaki disease with coronary artery aneurysm.
    Weng H; Peng Y; Pei Q; Jing F; Yang M; Yi Q
    Pediatr Res; 2021 Feb; 89(3):569-573. PubMed ID: 32316027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab as a novel therapy for refractory Kawasaki disease.
    Weiss JE; Eberhard BA; Chowdhury D; Gottlieb BS
    J Rheumatol; 2004 Apr; 31(4):808-10. PubMed ID: 15088313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytopenia: a complication of Kawasaki disease.
    Hara T; Mizuno Y; Akeda H; Fukushige J; Ueda K; Aoki T; Sunagawa H; Honda S; Hijii T; Yamaguchi Y
    Eur J Pediatr; 1988 Jan; 147(1):51-3. PubMed ID: 3338478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of 100 patients with Kawasaki disease.
    Tizard EJ; Suzuki A; Levin M; Dillon MJ
    Arch Dis Child; 1991 Feb; 66(2):185-8. PubMed ID: 1900405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kawasaki syndrome: still a fascinating enigma.
    Barron KS; Murphy DJ
    Hosp Pract (Off Ed); 1989 Oct; 24(10):51-60. PubMed ID: 2507564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin.
    Ichida F; Fatica NS; Engle MA; O'Loughlin JE; Klein AA; Snyder MS; Ehlers KH; Levin AR
    Pediatrics; 1987 Dec; 80(6):828-35. PubMed ID: 3684392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of patients with a high risk of coronary artery aneurysm in Kawasaki disease: indication for immunoglobulin therapy.
    Nakano H
    Prog Clin Biol Res; 1987; 250():287-97. PubMed ID: 3423043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.